Back to News << Taconic Acquires Xenbio
iTL Comments on XenBio Sale
Matthew Stadler
The sale of the XenBio business unit by Caliper is significant news to our market and client base. Published information suggests that continuing financial losses from their mouse model generating service spurred Caliper to improve their bottom line by selling the unit to Taconic to be absorbed into their services.
"As the world leader in delivering custom mouse models to academic and medical researches' remarked Paul Sheiffele, President and COO of iTL 'We believe it is important to indicate to our clients and the market in general that we are focused and committed to our clients and service.' iTL is in its 12th year of business and delivers custom mouse models to satisfied clients across the globe.
Caliper Sells XenBio for $11M
Ryan McBride, Xconomy : Boston
Caliper Life Sciences, a Hopkinton, MA-based provider of life sciences research products and services, said today that it has sold its small animal services business, Xenogen Biosciences (XenBio), to the laboratory rodent provider Taconic Farms for about $11 million. Taconic, headquartered in Hudson, NY, is also becoming the distributor of Caliper’s transgenic rodents that can indicate gene activation and drug responses with florescent light. Caliper (NASDAQ:CALP) acquired the XenBio business through its 2006 buyout of Xenogen.
Ryan McBride is Xconomy's correspondent. You can reach him at rmcbride@xconomy.com, or follow him on Twitter at http://twitter.com/Ryan_McBride.
http://www.xconomy.com/boston/2009/12/14/caliper-sells-xenbio-for-11m/